from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3750c/-

LFCtreatmentdescriptionclass of inhibitor

0.701

Amikacinug/mL Amikacintranslation

1.105

Cap5-10ug/mL Capreomycintranslation

0.581

Rox10-50 ug/mL Roxithromycintranslation

-0.044

SM2-5 ug/mL Streptomycintranslation

-0.379

Tet5-10 ug/mL Tetracyclinetranslation

-1.713

Rif0.2-5ug/mL Rifampicintranscription

-1.103

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.330

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.469

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.514

CPZ10-50 ug/mL Chlorpromazinerespiration

0.770

Clofazimine10-13 ug/mL Clofaziminerespiration

0.957

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.336

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.528

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.484

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.582

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.754

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.961

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.392

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.442

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.010

KCN5-20 ug/mL Potassium cyaniderespiration

0.789

NaN30.2-2 mM Sodium aziderespiration

1.412

Nigericin50 uM Nigericinrespiration

0.400

TRC10-150 ug/mL Triclosanrespiration

0.433

TRZ10-25 ug/mL Thioridazinerespiration

-1.218

Valinomycin0.5-10 uM Valinomycinrespiration

0.600

ZnSO42 mM ZnSO4respiration

-0.323

menadione6-10 ug/mL Menadionerespiration

-0.200

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.156

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.511

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.868

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.097

NRP_1Non-replicating persistence stage 1dosRassociated

0.355

Amp0.2mg/mL AmpicillincellWall

-0.105

Cephalexin20-100 ug/mL CephalexincellWall

0.369

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.091

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.283

EMB10-20 ug/mL EthambutolcellWall

-0.103

Eta12-40 ug/mL EthionamidecellWall

-0.608

INH0.2-0.4 ug/mL IsoniazidcellWall

0.078

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.878

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.365

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.454

BZA0.12 mg/mL BenzamidearomaticAmides

-0.230

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.363

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.731

H2O24 mM hydrogen peroxideDNAdamaging

0.478

Levo10 ug/mL LevofloxacinDNAdamaging

0.024

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.212

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.358

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.304

UVUV-irradiationDNAdamaging

-0.800

ARP41-4 ug/mL Antitubercular compound ARP4?

0.221

Antimycin12.5-50 ug/mL Antimycin A?

0.371

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.545

PA_110-50 ug/mL Antitubercular compound PA-1?

0.698

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.343

PA8240.2-2 ug/mL PA-824?

-1.452

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-1.219

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.025

Verapamil50 uM Verapamil?

0.474

mercaptoethanol2 mM 2-Mercaptoethanol?

0.622

methoxatin10-20 ug/mL Methoxatin?